Therefore, we implement NAC treatment to 8-week diabetic rats during feeding period and sevo-postC before reperfusion to test the hypothesis that NAC and sevo-postC can synergistically reduce myocardial IRI in diabetes and explore the roles of p-STAT3, FoxO1, APN, and CD36 in this procedure. The gene discussed is STAT3; the disease is diabetes mellitus.